Closing Bell: Cipher Pharmaceuticals Inc up on Friday (CPH)

In trading today, Cipher Pharmaceuticals Inc shares closed at $8.92 after opening the day at $8.38. It traded at a low of $8.38 to a high of $8.92.

The price advanced 6.95% from the previous day's close of $8.34.

During the day across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Cipher Pharmaceuticals Inc traded under CPH on the Toronto Stock Exchange (TSX).

Trading volume was 19,578 on 107 total trades. On average, Cipher Pharmaceuticals Inc has traded 14,499 shares over the last 5-days and 31,997 year-to-date.

The TSX overall saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, CPH.TO has traded as high as $10.33 (May 10,2024) and low as $3.35 (August 08,2023). Moreover, in the last 12 months, Cipher Pharmaceuticals Inc's shares have risen 137.87 percent, while they have soared 61.01% this year.

Following today's trading, Cipher Pharmaceuticals Inc has a market capitalization of $201.10 million on a float of 24,113 shares outstanding. Its annual EPS is $0.90.

Cipher Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Cipher Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 2 analysts according to Zacks. Currently, there are 1 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..